Print Page   |   Sign In   |   Join
News & Press: NASPAG News

LARC Extended Use Talking Points

Thursday, May 10, 2018   (0 Comments)
Posted by: Emily Freeman
Share |

Recent studies have demonstrated that three LARC methods are effective for longer than their labels indicate. ParaGard is currently FDA labeled with efficacy for 10 years, Nexplanon for 3 years of use and Mirena for 5 years. Studies support offering to extend Mirena®, ParaGard®, and Nexplanon® for off-label use for an additional 2 years beyond FDA approved labeling. Pharmacokinetic studies support extending Liletta for off-label use to 5 years, however there are not clinical trials to date. There is insufficient data about the extended use of Nexplanon in women with BMI >30.


Read the NASPAG Education Committee's latest document, LARC Extended Use Talking Points

Association Management Software Powered by YourMembership  ::  Legal